AbVitro's Series A Round

AbVitro raised a round of funding on June 03, 2013. Investors include Sante Ventures.

AbVitro's cutting edge technology platform accelerates the development of novel immunotherapies by identifying cancer-specific immune cells from natural immune responses at unprecedented resolution. B…

Articles about AbVitro's Series A Round: